Evidence map›Paper›PMID 19889729›Full record

ArticleJournal of leukocyte biology2010

Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Susan S Ishmael, Donald W MacGlashan

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. The safety and efficacy of sublingual and oral immunotherapy for milk allergy.The Journal of allergy and clinical immunology · 2012
    Trial
  3. Trial
  4. Association of a SYK promoter polymorphism with SYK expression and IgE-mediated histamine release.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Article
  11. The relationship between total cellular content of CD203c and cell surface expression on human basophils.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. IgE-dependent signaling as a therapeutic target for allergies.Trends in pharmacological sciences · 2012
    Review
  17. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Susan S IshmaelJohns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
Donald W MacGlashan

Funding

Interrelation between FcERI Expression, Cellular Sensitivity, In vivo ResponsesU19AI070345 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMILTON, ROBERT G · 2006 to 2010
$6.5M
REGULATION OF SECRETION FROM HUMAN BASOPHILSR01AI020253 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 1985 to 2009
$3.5M
NIAID NIH HHS AI070345NIAID NIH HHS AI20253
6 · The paper itself

Abstract

In human basophils from different subjects, maximum IgE-mediated histamine release and the level of syk protein expression correlate well. It is not clear when in the basophil's lifetime the set-point for syk expression is reached or how expression levels are determined for a given individual. An examination of syk expression in peripheral blood eosinophils, neutrophils, monocytes, B and T cells, DCs, and NK cells showed that with the exception of T cells, basophils were unique in expressing low levels of syk. No correlations were observed between syk expression in basophils and other types of leukocytes, suggesting a unique mechanism of regulation for basophils. The expression level of syk in CD34+ progenitors was approximately 11-fold higher than in peripheral blood basophils, and it remained at this level during maturation of the cells in IL-3 to a cell with characteristics of peripheral blood basophils. Down-regulation of syk expression in the culture-derived basophils was induced by culturing under conditions of chronic aggregation of FcepsilonRI. Syk was down-regulated to peripheral blood basophil levels in 50% of the cells. Despite the chronic aggregation of FcepsilonRI, the cells retained the same expression of FcepsilonRI, histamine content, and morphological staining of granules as cells not experiencing chronic aggregation. These results suggest that chronic stimulation through FcepsilonRI during basophil maturation might be a mechanism for down-regulating syk expression, while retaining other characteristics associated with mature peripheral blood basophils.

Indexed as

Antigens, CD34BasophilsCells, CulturedGene Expression RegulationHematopoietic Stem CellsHistamine ReleaseHumansImmunoglobulin EIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesReceptors, IgESyk KinaseAntigens, CD34Immunoglobulin EIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesReceptors, IgESyk KinaseSYK protein, human

Identifiers

PMID19889729
PMCPMC2812559
OpenAlexW2029070352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.